文献库 文献相关信息
- 题目:
- Multiple CDK/CYCLIND genes are amplified in medulloblastoma and supratentorial primitive neuroectodermal brain tumor.
- 作者:
- Li(Meihua),Lockwood(Will),Zielenska(Maria),Northcott(Paul),Ra(Young Shing),Bouffet(Eric),Yoshimoto(Maisa),Rutka(James T),Yan(Hai),Taylor(Michael D),Eberhart(Charles),Hawkins(Cynthia E),Lam(Wan),Squire(Jeremy A),Huang(Annie)
- 状态:
- 发布时间2012-06-11 , 更新时间 2012-06-11
- 期刊:
- Cancer Genet
- 摘要:
- Embryonal brain tumors, which include medulloblastoma and the more aggressive supratentorial primitive neuroectodermal tumor (sPNET), comprise one of the largest group of malignant pediatric brain tumors. We observed in high resolution array comparative genomic hybridization and polymerase chain reaction analyses that several different components of the CDK/CYCLIND/pRB regulatory complex, including the CDK4/6 and CCND1/2 loci, are targets of gene amplification in medulloblastoma and sPNET. CDK6 and CCND1 gene amplification were respectively most common and robust, and overall CDK/CYCLIND gene amplification was more commonly observed in sPNET (25%) than medulloblastoma (1-5%). CDK6 overexpression enhanced in vitro and in vivo oncogenicity and endogenous CDK6 or CCND1 knockdown decreased pRB phosphorylation and impaired cell cycle progression in both medulloblastoma and sPNET cell lines. Although animal models implicate the pRB tumor suppressor pathway in medulloblastoma and sPNET, mutations of RB1 or the related INK4 tumor suppressor loci are rare in primary human tumors. Our data suggest that CDK/CYCLIND gene amplification may represent important mechanisms for functional inactivation of pRB in medulloblastoma and sPNET.
- 语言:
- eng
- DOI:
- 10.1016/j.cancergen.2012.03.002
DataTable pData
微信公众号
关注微信订阅号，实时查看信息，关注医学生物学动态。
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备13024435号-2
